Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

603
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
603

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spastic Quadriplegia Resulting From a Pathogenic Variant in the <i>SPAST</i> Gene: A First Report.

Case reports in neurological medicine·2026
Same author

What do postpartum women know about congenital CMV infection in Greece - A national cross-sectional study.

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

Cerebral Oximetry in Extremely Preterm Infants: 2-Year Follow-Up of the SafeBoosC-III Randomized Clinical Trial.

JAMA pediatrics·2026
Same author

Association of Fetal Growth Retardation with Postnatal Osteoprotegerin Concentrations and Aortic Intima-Media Thickness.

Diseases (Basel, Switzerland)·2026
Same author

Treatment guided by cerebral oximetry in newborns receiving invasive mechanical ventilation: study protocol for step one of the SafeBoosC-IIIv randomised clinical trial.

Trials·2026
Same author

Parental Knowledge, Attitudes and Practices About Streptococcal Pharyngotonsillitis and Antibiotic Use in Western Greece.

Antibiotics (Basel, Switzerland)·2026

Related Experiment Video

Updated: Nov 28, 2025

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.5K

Neonatal meningococcal disease: an update.

Dimitrios Filippakis1, Despoina Gkentzi1, Gabriel Dimitriou1

  • 1Department of Paediatrics, Patras Medical School, University of Patras, Patras, Greece.

The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
|November 25, 2020
PubMed
Summary
This summary is machine-generated.

Neonatal meningococcal disease is rare but deadly, with unknown incidence. Early suspicion and treatment are crucial for survival and preventing neurodevelopmental issues in infants.

Keywords:
Neonatemeningitidisneisseria

More Related Videos

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

8.6K
Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
08:27

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

11.4K

Related Experiment Videos

Last Updated: Nov 28, 2025

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.5K
Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

8.6K
Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
08:27

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

11.4K

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Neisseria meningitidis (meningococcus) is a common cause of sepsis in children.
  • Meningococcal disease is rarely observed in neonates, with undefined incidence.
  • This review focuses on meningococcal infections in the neonatal period.

Purpose of the Study:

  • To summarize published data on meningococcal disease in neonates.
  • To review the incidence, presentation, and outcomes of neonatal meningococcal infections.
  • To highlight the importance of early diagnosis and management.

Main Methods:

  • Systematic review of published studies on neonatal meningococcal disease.
  • Data extraction from global case reports.
  • Literature synthesis on transmission, risk factors, and clinical characteristics.

Main Results:

  • Neonatal meningococcal disease, though rare, has high mortality and severe neurodevelopmental complications.
  • Clinical presentation is atypical with rapid deterioration (<12 hours).
  • Risk factors include maternal genitourinary colonization and parental carriage; transmission routes are intrauterine, intrapartum, or postpartum.

Conclusions:

  • Neonatal meningococcal disease is a rare, potentially fatal condition requiring high clinical suspicion.
  • Assess maternal genitourinary colonization and parental carriage, especially in early-onset cases.
  • Prompt therapy and long-term follow-up are essential for improving outcomes and detecting sequelae.